Koreatown Center Grand Opening 2
Astiva Health, Inc. Celebrates Grand Opening of New Activity Center in Los Angeles-Koreatown with Support from Rep. Michelle Steel
16 févr. 2024 11h27 HE | Astiva Health
ORANGE, Calif. , Feb. 16, 2024 (GLOBE NEWSWIRE) -- via IBN -- Astiva Health Inc., a fast-growing Medicare Advantage Prescription Drug (MAPD) health plan dedicated to reshaping personalized and...
ibn.png
IBN Spotlights Astiva Health CEO Dr. Tri T. Nguyen on The Bell2Bell Podcast
30 janv. 2024 08h17 HE | InvestorBrandNetwork (IBN)
LOS ANGELES, Jan. 30, 2024 (GLOBE NEWSWIRE) -- IBN, a multi-dimensional communications organization engaged in connecting public companies with the investment community, proudly announces the airing...
astiva logo.jpg
Astiva Health Files Statement for Proposed Initial Public Offering
15 déc. 2023 08h00 HE | Astiva Health
ORANGE, Calif., Dec. 15, 2023 (GLOBE NEWSWIRE) -- via IBN -- Astiva Health Inc., a fast-growing Medicare Advantage Prescription Drug (MAPD) health plan dedicated to reshaping personalized and...
astiva logo.jpg
Astiva Health Announces Strategic Expansion Across Three Southern California Counties
12 déc. 2023 09h33 HE | Astiva Health
ORANGE, Calif., Dec. 12, 2023 (GLOBE NEWSWIRE) -- via IBN -- Astiva Health Inc., a fast-growing Medicare Advantage Prescription Drug (MAPD) health plan dedicated to reshaping personalized and...
Research Nester Logo.jpg
Dextromethorphan Market revenue to reach USD 550 Million by 2035, says Research Nester
20 sept. 2023 07h30 HE | Research Nester
New York, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The global dextromethorphan market size is slated to expand at ~4% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 550...
Straits Research Pvt Ltd
Opioids Market Size is projected to reach USD 32.25 billion by 2031, growing at a CAGR of 1.95%: Straits Research
29 juin 2023 11h10 HE | Straits Research
New York, United States, June 29, 2023 (GLOBE NEWSWIRE) -- Opioids are medications used to treat severe or persistent pain, such as chronic headaches and backaches, by patients recovering from...
Inmar Launches Consu
Inmar Launches Consumer Drug Take-Back Program to Help Organizations and Individuals Combat Opioid Epidemic
25 oct. 2017 17h33 HE | Inmar, Inc.
Winston-Salem, NC, Oct. 25, 2017 (GLOBE NEWSWIRE) -- Inmar, Inc. has launched a Consumer Drug Take-Back Program to help in the battle against prescription opioid abuse throughout the United States....
Bucking the National
Bucking the National Trend, NJ Captures $1.6 Billion in Prescription Drug Savings Without Cutting Benefits or Shifting Costs to Public Employees
11 juil. 2017 10h08 HE | America's Agenda
TRENTON, N.J., July 11, 2017 (GLOBE NEWSWIRE) -- America’s Agenda announces the State of New Jersey has netted an unprecedented $1.6 billion, or 18%, reduction of its prescription drug spend over...